Alliance for Regenerative Medicine

The Alliance for Regenerative Medicine (ARM) is the preeminent international organization focused specifically on the issues facing regenerative medicine and advanced therapies. We are advocates for progress in gene therapy, cell therapy, and tissue engineering.

Working with our members and policymakers, we foster investment, research & development, and successful commercialization of safe, effective, and transformational therapies for patients around the world.

Alliance members work together to:

Introduce and support policies that pave the way for development of new regenerative medicine therapies, medical devices and diagnostics.

Coalesce multiple, diverse stakeholders to ensure the healthcare system supports ready access to regenerative medicine products (i.e., U.S. and international government agencies, private insurers, providers, consumer groups, private healthcare enterprises)
Promote government and private funding of R&D in regenerative medicine.

Create visibility for advances in the field.

Work with regulators including the Food and Drug Administration (FDA) to encourage more rapid clinical translation of regenerative medicine technologies.

Develop sustainable business models and improve access to capital.

Provide broad-based education about regenerative medicine, including potential treatments for chronic diseases.

Encourage a global dialogue about the new meaning of treatment, prevention and healthcare, and the evolving prospects for human health that derive from regenerative medicine.